Exchange: TSX·Updated 03:45 PM EDT

TH.TSX Theratechnologies Inc.

$4.47
$0.23
(4.89%)
Today
Reported EarningsJul 9
Mkt Cap$205.53M
Vol35,472.00

About TH.TSX

Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which is an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montréal, Canada.
50

Neutral Sentiment

How do you feel about TH.TSX?

Advertisement|Remove ads.